Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia

Br J Haematol. 2000 Jul;110(1):29-40. doi: 10.1046/j.1365-2141.2000.02028.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / pharmacology
  • Antimetabolites, Antineoplastic / therapeutic use
  • Child
  • Cytarabine / administration & dosage
  • Cytarabine / pharmacology
  • Cytarabine / therapeutic use
  • Drug Administration Schedule
  • Etoposide / administration & dosage
  • Etoposide / pharmacology
  • Etoposide / therapeutic use
  • Humans
  • Mercaptopurine / administration & dosage
  • Mercaptopurine / pharmacology
  • Mercaptopurine / therapeutic use
  • Methotrexate / administration & dosage
  • Methotrexate / pharmacology
  • Methotrexate / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Teniposide / administration & dosage
  • Teniposide / pharmacology
  • Teniposide / therapeutic use
  • Thioguanine / administration & dosage
  • Thioguanine / pharmacology
  • Thioguanine / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • Cytarabine
  • Etoposide
  • Teniposide
  • Mercaptopurine
  • Thioguanine
  • Methotrexate